Study finds 96% of Covid-19 patients have antibodies year after recovery

The study looked at results from 250 people aged 21-78 who tested positive for the virus between February and April last year

Coronavirus UK
ANI Asia
2 min read Last Updated : May 22 2021 | 7:07 PM IST

A study by Japan's Yokohama City University showed that 96 per cent of people previously infected with COVID-19 still had antibodies a year after recovery, Kyodo News Agency reported.

The study looked at results from 250 people aged 21-78 who tested positive for the virus between February and April last year and found that those Covid-19 patients who showed more severe symptoms all had antibodies in the following year, while 97 per cent of those with mild or no symptoms had antibodies in the first six months after being ill.

The study also found that only 69 per cent of people who were sick with mild or no symptoms of Covid-19 last year had antibodies to fight the South African variant six months after being ill, 75 per cent against the Indian variant, 81 per cent against the Brazilian variant and 85 per cent against the UK variant. The study further showed that these percentages declined in the following year.

The study concluded that former COVID-19 patients who were ill in the first few months of the pandemic, especially if they had mild or no symptoms, must still be vaccinated in order to avoid being infected with a COVID-19 variant from the United Kingdom, South Africa and Brazil.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: May 22 2021 | 7:07 PM IST

Next Story